Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

Trane Technologies Surpasses Q2 Estimate, Revises FY23 Outlook

By Lekha Gupta
August 2, 12:19 PM
Trane Technologies PLC (NYSE: TT) reported Q2 2023 revenue growth of 12% Y/Y on a reported and 11% Y/Y on an organic basis to $4.71 billion, beating 

TT

Read More
2 minute read
  • Exclusives
  • General
  • Large Cap
  • Markets
  • News
  • Tech
  • Top Stories
  • Topics
  • Trading Ideas

EXCLUSIVE: AI Bubble In Sight? ‘Cow Guy’ Says ‘Sell’ When Your Uber Driver Buys In

By AJ Fabino
August 2, 11:47 AM
Scott Shellady, the finance veteran widely known as the “Cow Guy,” spoke candidly with Benzinga on Wednesday about…

GOOG

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine

By Vandana Singh
August 2, 11:18 AM
GSK Plc (NYSE: GSK) has sued Pfizer Inc (NYSE: PFE) in Delaware court, alleging that Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK's four patent rights in its RSV 

GSK

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • News

AmerisourceBergen Lifts 2023 Forecast On Higher Demand For Weight-Loss and Diabetes Products, Cushioning Lower COVID-19 Sales

By Vandana Singh
August 2, 10:49 AM
Drug distributor AmerisourceBergen Corporation's (NYSE: ABC) Q3 FY23 adjusted EPS reached $2.92, up 11.5% Y/Y, beating the 

ABC

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Haleon Lifts Annual Sales Forecasts, Says Pricing & Efficiencies Offset Inflationary Pressures

By Vandana Singh
August 2, 10:40 AM
Haleon PLC (NYSE: HLN) reported 

HLN

Read More
1 minute read
  • Dividends
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

BorgWarner Q2 Earnings Exceed Expectations, Revises FY23 Outlook

By Lekha Gupta
August 2, 9:49 AM
BorgWarner Inc (NYSE: BWA) reported a Q2 FY23 sales growth of 20% Y/Y to $4.52 billion, beating 

BWA

Read More
2 minute read
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • M&A
  • Markets
  • News

Phillips 66 Tops Q2 Estimates, Expects To Deliver $10B To $12B Shareholder Distribution By End Of 2024

By Lekha Gupta
August 2, 9:22 AM
Phillips 66 (NYSE: PSX) reported Q2 adjusted EPS of $3.87, 

PSX

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

CVS Health Q2 Profit Falls But Beats Estimate, Initiates Restructuring To Cut Costs, Lowers Annual Outlook

By Vandana Singh
August 2, 9:20 AM
CVS Health Corp's (NYSE: CVS) Q2 sales increased 10.3% Y/Y to $88.9 billion, beating the consensus of $86.74 billion, driven by 

CVS

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Why Is Humana Stock Trading Higher Today?

By Vandana Singh
August 2, 9:10 AM
Humana Inc (NYSE: HUM) reported Q2 adjusted EPS of $8.94 from $8.76 a year ago, 

HUM

Read More
2 minute read
  • Buybacks
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

DuPont Beats Q2 Earnings Estimates, Revises FY23 Outlook

By Lekha Gupta
August 2, 8:24 AM
DuPont De Nemours, Inc. (NYSE: DD) reported a Q2 FY23 sales decrease of 7% Y/Y to $3.09 billion, beating 

DD

Posts pagination

Previous 1 … 245 246 247 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service